Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma
Clinical trial NCT01615029 · COMPLETED
Trial details
- NCT number
- NCT01615029
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-26
- Primary completion
- 2015-10-02
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.